Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1996-10-21
|
pubmed:abstractText |
In Smith-Lemli-Opitz syndrome (SLOs), 7-dehydrocholesterol (7-DHC) accumulated because there is a block in the pathway for synthesis of cholesterol via 7-DHC. Prenatal diagnosis of SLOs has been achieved by analysis of 7-DHC in amniotic fluid obtained at 16-18 wk from pregnancies at risk. The purpose of this study was to investigate 7-DHC and cholesterol concentrations in chorionic villus (CV) samples with a view to performing first trimester prenatal diagnosis. Using a sensitive gas chromatography-mass spectrometry assay it was possible to detect 7-DHC in CV samples obtained as early as 7 wk of gestation. The ration of 7-DHC to cholesterol in placental tissue was shown to be relatively constant over the gestational period of 7-18 wk. We therefore proceeded to analyze the 7-DHC/cholesterol ration in CV samples taken at 10-12 wk of gestation from three pregnancies at risk for SLOs. The results were as follows: patient A, 1.10 x 10(-3); patient B, 1.80 x 10(-3); patient C, 0.091; control range for CVS (8-12 wk), 3.10 x 10(-4) to 1.62 x 10(-3) (mean +/- 2SD; n = 5). The fetus of patient C was diagnosed as affected by SLOs, and the parents requested termination. Analysis of cultured skin fibroblasts confirmed the diagnosis. Pregnancies A and B were diagnosed unaffected, and this was confirmed first by amniocentesis and then by the birth of normal infants at term. We conclude that synthesis of cholesterol via 7-DHC is occurring in the placenta and/or fetus at 10 wk of gestation and that prenatal diagnosis by CV biopsy is possible.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/7-dehydrocholesterol reductase,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Oxidoreductases,
http://linkedlifedata.com/resource/pubmed/chemical/Oxidoreductases Acting on CH-CH...
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0031-3998
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
816-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8726234-Amniocentesis,
pubmed-meshheading:8726234-Amniotic Fluid,
pubmed-meshheading:8726234-Case-Control Studies,
pubmed-meshheading:8726234-Cholesterol,
pubmed-meshheading:8726234-Chorionic Villi,
pubmed-meshheading:8726234-Chorionic Villi Sampling,
pubmed-meshheading:8726234-Female,
pubmed-meshheading:8726234-Gestational Age,
pubmed-meshheading:8726234-Humans,
pubmed-meshheading:8726234-Oxidoreductases,
pubmed-meshheading:8726234-Oxidoreductases Acting on CH-CH Group Donors,
pubmed-meshheading:8726234-Pregnancy,
pubmed-meshheading:8726234-Prenatal Diagnosis,
pubmed-meshheading:8726234-Smith-Lemli-Opitz Syndrome
|
pubmed:year |
1996
|
pubmed:articleTitle |
First trimester prenatal diagnosis of Smith-Lemli-Opitz syndrome (7-dehydrocholesterol reductase deficiency).
|
pubmed:affiliation |
Biochemistry Unit, Institute of Child Health, London, United Kingdom.
|
pubmed:publicationType |
Journal Article
|